Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENT (Tables)

v3.20.2
FAIR VALUE MEASUREMENT (Tables)
6 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of fair value on recurring basis

The following table sets forth by level within the fair value hierarchy the Company’s derivative financial instruments that were accounted for at fair value on a recurring basis as of March 31, 2020:

 

Description  

Quoted Prices in

Active Markets for

Identical Assets
(Level 1)

   

Significant Other 

Observable Inputs
(Level 2)
 

   

Significant Other

Unobservable 

Inputs
(Level 3)

    Total Fair
Value as of
 
Derivative Financial Instrument at September 30, 2019   $     $ 3,534,456     $     $ 3,534,456  
New Derivative Instruments Issued           880,462             880,462  
Derivative Instruments Converted           (458,893 )           (458,893 )
Change in fair value           (1,738,803 )           (1,738,803 )
Derivative Financial Instrument at March 31, 2020   $     $ 2,217,222     $     $ 2,217,222